Novel and traditional lipid profiles in Metabolic Syndrome reveal a high atherogenicity

Low-density-lipoprotein cholesterol (LDL-c) guides lipid-lowering therapy, although other lipid parameters could better reflect cardiovascular disease (CVD) risk. Discordance between these parameters and LDL-c has not been evaluated in metabolic syndrome (MetS) patients. We characterized a comprehen...

Descripción completa

Detalles Bibliográficos
Autores principales: Paredes, Sílvia, Fonseca, Liliana, Ribeiro, Laura, Ramos, Helena, Oliveira, José Carlos, Palma, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692317/
https://www.ncbi.nlm.nih.gov/pubmed/31409878
http://dx.doi.org/10.1038/s41598-019-48120-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692317/
https://www.ncbi.nlm.nih.gov/pubmed/31409878
http://dx.doi.org/10.1038/s41598-019-48120-5

Ejemplares similares